| 1202 |
Centers for Disease Control and Prevention |
Html |
en |
Announcements: Epidemic Intelligence Service ApplicationDeadline - August 15, 2014 |
Applications are being accepted for CDC's July 2015–June 2017 Epidemic Intelligence Service (EIS) program. EIS is a 2-year, postgraduate program of service and on-the-job training for health professionals interested in the practice of epidemiology. Each year, EIS selects approximately 80 persons from applicants around the world and provides them with opportunities to gain hands-on experience in epidemiology at CDC or at state or local health departments. |
| disease detectives | 0.659769 |
| CDC | 0.743103 |
| endorsement | 0.566729 |
| behavioral science | 0.651731 |
| hands-on experience | 0.655559 |
| Human Services | 0.751313 |
| MMWR HTML versions | 0.7639 |
| U.S. Department | 0.747662 |
| permanent residency | 0.646525 |
| limited number | 0.648064 |
| J-1 visa | 0.646452 |
| EIS officers | 0.870918 |
| electronic PDF version | 0.751019 |
| Non-U.S. citizens | 0.642923 |
| EIS online application | 0.968842 |
| health professionals | 0.82189 |
| Epidemic Intelligence Service | 0.822155 |
| Contact GPO | 0.671095 |
| commercial sources | 0.645155 |
| public health degree | 0.817618 |
| EIS | 0.99435 |
| current prices | 0.639857 |
| occupy leadership positions | 0.794942 |
| original paper copy | 0.745606 |
|
| public health agencies | 0.824475 |
| U.S. citizenship | 0.664395 |
| nursing degree | 0.656126 |
| on-the-job training | 0.678236 |
| U.S. Government Printing | 0.759411 |
| original MMWR paper | 0.758485 |
| EIS class | 0.85271 |
| MMWR readers | 0.651505 |
| character translation | 0.63761 |
| epidemiology | 0.641963 |
| local health departments | 0.820328 |
| format errors | 0.639303 |
| doctoral-level scientist | 0.66581 |
| typeset documents | 0.646094 |
| trade names | 0.645257 |
| official text | 0.635843 |
| population health perspective | 0.814346 |
| postgraduate program | 0.669941 |
| clinical training | 0.651404 |
| non-CDC sites | 0.643684 |
| clinical specialty | 0.649573 |
| unrestricted U.S. license | 0.795114 |
| electronic conversions | 0.635486 |
| program details | 0.65065 |
|
CLICK HERE |
| 4463 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance for the Detection of Novel Influenza A Virus Using Rapid Influenza Diagnostic Tests |
null |
| influenza | 0.968319 |
| RIDT result | 0.410118 |
| negative RIDT result | 0.405831 |
| rRT-PCR Swine Flu | 0.396264 |
| CDC rRT-PCR Swine | 0.39558 |
| false negative results | 0.360266 |
| novel influenza | 0.866032 |
| positive RIDT results | 0.361671 |
| influenza treatment decisions. | 0.530695 |
| seasonal influenza viruses | 0.610087 |
| clinically compatible illness | 0.384352 |
| viral culture | 0.383742 |
| influenza A viruses. | 0.517854 |
| influenza assay results | 0.560219 |
| low influenza activity | 0.554379 |
| influenza virus infection | 0.696726 |
| virus isolation | 0.36448 |
| Swine Flu Panel | 0.395215 |
| influenza laboratory tests | 0.542663 |
| e.g. seasonal influenza | 0.554934 |
| influenza viral nucleoprotein | 0.552149 |
| versus seasonal influenza | 0.529317 |
| influenza A virus | 0.569536 |
| respiratory specimens | 0.386917 |
|
| seasonal influenza viruses2. | 0.543225 |
| influenza B viruses | 0.542773 |
| seasonal influenza | 0.686548 |
| Influenza Diagnostic Test | 0.526176 |
| influenza activity periods | 0.52355 |
| commercially available RIDTs | 0.41293 |
| influenza virus infection. | 0.558022 |
| virus infection. Information | 0.393365 |
| clinical testing recommendations. | 0.370182 |
| Influenza Type | 0.498706 |
| RIDTs | 0.414289 |
| direct antigen detection | 0.366433 |
| antigen detection tests | 0.418864 |
| serial serological testing | 0.362855 |
| specimen collection | 0.383117 |
| e.g. novel H1N1 | 0.38661 |
| influenza infections | 0.496572 |
| influenza antiviral agents | 0.534636 |
| influenza testing | 0.552532 |
| influenza surveillance | 0.525088 |
| influenza viruses | 0.711843 |
| influenza virus types | 0.604829 |
| rapid influenza | 0.60256 |
|
CLICK HERE |
| 6063 |
Centers for Disease Control and Prevention |
Html |
en |
Iron oxide dust and fume (as Fe) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7824 |
Centers for Disease Control and Prevention |
Html |
en |
Cervical Cancer - Health Communication |
Cervical Cancer - Gateway to Health Communication - CDC |
| lesions | 0.217242 |
| newborn death | 0.284563 |
| total hysterectomy | 0.27705 |
| HPV cancers | 0.556851 |
| children | 0.240968 |
| immune systems | 0.278805 |
| Jacquelyn | 0.274504 |
| excision | 0.21994 |
| inability | 0.218425 |
| vagina | 0.218953 |
| lives | 0.217866 |
| anus | 0.220038 |
| common virus | 0.287753 |
| cervical cancers | 0.326706 |
| infected area | 0.302927 |
| cervical cancer | 0.377528 |
| HPV vaccines | 0.461784 |
| preschoolers | 0.216689 |
| Young women | 0.275437 |
| HPV infections | 0.594425 |
| medical appointments | 0.275294 |
| women | 0.360418 |
| lasting effects | 0.284858 |
| United States | 0.28651 |
|
| throat | 0.216499 |
| invasive testing | 0.28099 |
| changes | 0.234861 |
| Everyone. HPV | 0.478426 |
| intimate partner | 0.281185 |
| Teen boys | 0.279031 |
| HPV vaccine | 0.830288 |
| precancers | 0.233417 |
| vulva | 0.221111 |
| HPV | 0.930391 |
| Human papillomavirus | 0.298875 |
| men | 0.329752 |
| penis | 0.218024 |
| kids | 0.231914 |
| cervix | 0.21875 |
| HPV vaccine series | 0.642365 |
| Yes. HPV vaccination | 0.537919 |
| young men | 0.274422 |
| people | 0.256398 |
| way | 0.217188 |
| cancer survivor | 0.277172 |
| cells | 0.233564 |
| low birthweight | 0.289817 |
| time | 0.227281 |
|
CLICK HERE |
| 7951 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | State-Based and DemographicVariation in Parent-Reported Medication Rates forAttention-Deficit/Hyperactivity Disorder, 2007-2008 - CDC |
Medication is the most effective treatment of attention-deficit/hyperactivity disorder (ADHD), a common neurobehavioral disorder of childhood. We used data from the 2007-2008 National Survey of Children’s Health to calculate weighted estimates of parent-reported ADHD and medication treatment among US children aged 4 to 17 years, by state and sex-stratified age. |
| North Carolina | 0.295874 |
| Medication rates | 0.360853 |
| ADHD medication treatment | 0.756217 |
| lowest state-based rates | 0.34233 |
| Child Health Bureau | 0.290518 |
| current diagnosis | 0.344283 |
| parent-reported ADHD | 0.52916 |
| medication treatment question | 0.394125 |
| current ADHD diagnosis | 0.758632 |
| ADHD medications | 0.474676 |
| complex survey design | 0.294174 |
| overall response rate | 0.288716 |
| effective treatment | 0.315562 |
| Disease Control | 0.314736 |
| ADHD medication shortages | 0.558243 |
| children | 0.398405 |
| stimulant medication | 0.346085 |
| common ADHD medications | 0.459422 |
| Future state-based investigations | 0.320571 |
| claims data | 0.28938 |
| nonresponse-adjusted weight variables | 0.288147 |
| monitoring ADHD treatment | 0.52606 |
| sex-stratified age | 0.351054 |
| medication treatment | 0.829485 |
| mental health services | 0.288387 |
|
| different medication | 0.340239 |
| medication treatment factors | 0.435795 |
| parent-reported ADHD diagnosis | 0.513849 |
| landline telephone survey | 0.298603 |
| school-aged children | 0.3149 |
| ADHD prevalence | 0.422493 |
| Research Triangle Park | 0.287558 |
| current medication treatment | 0.412089 |
| ADHD | 0.97472 |
| Medication treatment rates | 0.418891 |
| state-based rates | 0.418335 |
| Children’s Health | 0.318215 |
| common neurobehavioral disorder | 0.401171 |
| state-based investigations | 0.34235 |
| survey design change | 0.287743 |
| ADHD medication | 0.849841 |
| ADHD subtypes | 0.426782 |
| current ADHD | 0.776 |
| National Survey | 0.302398 |
| attention-deficit/hyperactivity disorder | 0.313863 |
| ADHD diagnosis question | 0.497474 |
| public health efforts | 0.306104 |
| state-based policy | 0.287045 |
| claims data sources | 0.285981 |
|
CLICK HERE |
| 9236 |
Centers for Disease Control and Prevention |
Html |
en |
Case Count Maps for Aug 2013 | Outbreak Investigation | Cyclosporiasis | CDC |
null |
| Arkansas | 0.324096 |
| states | 0.324977 |
| Nebraska | 0.324356 |
| New York City | 0.915959 |
| number | 0.324604 |
| total | 0.325119 |
| EDT | 0.342731 |
| Missouri | 0.323878 |
| Wisconsin | 0.324227 |
| area | 0.324534 |
| New York | 0.994715 |
| cases | 0.548758 |
| Cyclospora infection | 0.606589 |
| South Dakota | 0.217781 |
|
| Data | 0.579611 |
| Minnesota | 0.323509 |
| Kansas | 0.323804 |
| California | 0.21002 |
| Florida | 0.324297 |
| New Jersey | 0.503697 |
| Iowa | 0.324404 |
| Texas | 0.324474 |
| Illinois | 0.324167 |
| New Hampshire | 0.345783 |
| Connecticut | 0.323526 |
| Louisiana | 0.313571 |
| Ohio | 0.323487 |
| Georgia | 0.323947 |
|
CLICK HERE |
| 10321 |
Centers for Disease Control and Prevention |
Html |
en |
HAN Archive - 00349 - Nationwide Shortage of Doxycycline |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| doxycycline monohydrate | 0.663333 |
| Health-System Pharmacists | 0.417782 |
| manufacturing issues | 0.362443 |
| doxycycline | 0.922308 |
| Health Alert Network | 0.415481 |
| fatal Rocky Mountain | 0.398792 |
| broad-spectrum antibiotics | 0.366747 |
| oral treatment | 0.365043 |
| malaria endemic country | 0.407823 |
| Mountain Spotted Fever | 0.397445 |
| website (http://www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm). | 0.544116 |
| American Society | 0.409485 |
| doxycycline hyclate | 0.760365 |
| additional information | 0.410382 |
| Infectious Diseases Society | 0.396876 |
| doxycycline availability | 0.624608 |
| intravenous doxycycline hyclate | 0.691149 |
| (http://www.ashp.org/default.aspx). | 0.408771 |
| CDC malaria website | 0.410333 |
| treatment delay | 0.37383 |
| possible treatment alternative | 0.418215 |
| significantly higher risk | 0.392401 |
| Health care professionals | 0.402107 |
| similar shortage | 0.403272 |
| fatal outcome | 0.47569 |
|
| increased pricing | 0.396677 |
| treatment | 0.44001 |
| equally effective alternative | 0.409387 |
| empiric treatment | 0.37231 |
| Drug Administration | 0.368022 |
| STD Treatment Guidelines | 0.411149 |
| local health department | 0.395888 |
| increased demand | 0.361117 |
| drug shortages | 0.415808 |
| sexually transmitted infections | 0.416926 |
| lyme disease | 0.555537 |
| state health department | 0.400873 |
| penicillin allergy.Alternative regimens | 0.397735 |
| Rocky Mountain | 0.456527 |
| Tickborne Rickettsial Diseases | 0.450818 |
| possible antibiotics | 0.361054 |
| rickettsial infections | 0.723589 |
| specific life-threatening contraindications | 0.395005 |
| health department | 0.402956 |
| Disease Treatment Information | 0.437334 |
| Lyme disease prophylaxis | 0.482867 |
| Sexually Transmitted Diseases | 0.398352 |
| suspension doxycycline calcium | 0.686963 |
| FDA Drug Shortage | 0.549646 |
|
CLICK HERE |
| 11122 |
Centers for Disease Control and Prevention |
Html |
en |
2008 National Report on Biochemical Indicators of Diet and Nutrition - Table 5.6 |
null |
| µg/g creatinine | 0.317887 |
| Estimate | 0.26112 |
| Total population | 0.300139 |
| urine concentrations | 0.550688 |
| Males | 0.421745 |
| Search Form Controls | 0.309235 |
| conf. interval | 0.859268 |
| creatinine | 0.34612 |
| Urinary equol | 0.257087 |
| file | 0.287319 |
| Clifton Road Atlanta | 0.250093 |
| Urinary enterolactone | 0.966475 |
| Geometric mean | 0.853197 |
| small cell size | 0.576701 |
| Urinary O-desmethylangolensin | 0.325667 |
| Serum | 0.305065 |
| u.s. population | 0.574457 |
| Nutrition Examination Survey | 0.789818 |
| Biochemical Indicators | 0.261749 |
| National Report | 0.255229 |
| Tweet Share Compartir | 0.263089 |
|
| Urinary enterodiol | 0.257037 |
| greater uncertainty | 0.42997 |
| percentiles | 0.410821 |
| Mexican Americans | 0.396729 |
| Table | 0.437338 |
| non-hispanic whites | 0.385537 |
| Iodine Urinary iodine | 0.255301 |
| Lignans Urinary genistein | 0.258322 |
| Fat-Soluble Vitamins | 0.25022 |
| Sample | 0.304538 |
| page options Skip | 0.258437 |
| Search Controls | 0.257948 |
| non-hispanic blacks | 0.390643 |
| Iron-Status Indicators Serum | 0.250317 |
| total U.S. population | 0.297629 |
| National Health | 0.539537 |
| Urinary daidzein | 0.257112 |
| Trace Elements | 0.252598 |
| Serum transferrin saturation | 0.252926 |
| Home Executive Summary | 0.251267 |
| page | 0.363285 |
|
CLICK HERE |
| 13198 |
Centers for Disease Control and Prevention |
Html |
en |
Cancer Screening Test Use - United States, 2013 |
Susan A. Sabatino, MD1, Mary C. White, ScD1, Trevor D. |
| recent cervical cancer | 0.395933 |
| routine screening | 0.57903 |
| CRC test | 0.529943 |
| National Health Interview | 0.371318 |
| NHIS data | 0.487068 |
| NHIS survey | 0.362832 |
| subgroups | 0.364815 |
| low screening | 0.488507 |
| screening definitions | 0.481078 |
| privately insured respondents | 0.398357 |
| large screening disparities | 0.571463 |
| Pap test | 0.668287 |
| colorectal cancer | 0.507295 |
| CRC screening | 0.804448 |
| recent CRC tests | 0.454136 |
| adequate prior screening | 0.532538 |
| cancer screening target | 0.587932 |
| Pap test data | 0.388468 |
| Cancer Control Program | 0.45191 |
| National Colorectal Cancer | 0.363929 |
| occult blood test | 0.381773 |
| usual source | 0.65019 |
| screening percentages | 0.495287 |
| Colorectal Cancer Control | 0.454137 |
|
| USPSTF recommendations | 0.375166 |
| CRC screening options | 0.613936 |
| women | 0.551648 |
| recent data | 0.369839 |
| care | 0.369035 |
| low-cost screening | 0.484074 |
| Sample Adult file | 0.362927 |
| Carrie N. Klabunde | 0.36478 |
| targets | 0.454878 |
| recent U.S. Preventive | 0.36818 |
| privately insured women | 0.509782 |
| Mary C. White | 0.365582 |
| percentage points | 0.580048 |
| Publicly insured respondents | 0.398273 |
| Healthy People | 0.930418 |
| Susan A. Sabatino | 0.361746 |
| Imputed Income files | 0.363036 |
| sample adult response | 0.360664 |
| Services Task Force | 0.363821 |
| health care coverage | 0.366724 |
| Cervical cancer screening | 0.678114 |
| CRC testing options | 0.420825 |
| preventive services | 0.423847 |
| recent Pap test | 0.40752 |
|
CLICK HERE |
| 13666 |
Centers for Disease Control and Prevention |
Image |
null |
Protect All the Skin You're In |
null |
|
|
CLICK HERE |